Daily BriefsIndia

Daily Brief India: Infosys Ltd, Concord Biotech Ltd, Apeejay Surrendra Park Hotel and more

In today’s briefing:

  • India: Free Float Changes & Passive Flows in February
  • Concord Biotech’s US$650m Lock-Up Expiry – Some Could Be Tempted to Book Multi-Bagger Gains
  • Apeejay Surrendra Park Hotels IPO – Has Bounced Back Strongly, at a Decent Discount


India: Free Float Changes & Passive Flows in February

By Brian Freitas

  • Companies in India have disclosed their shareholding pattern as of end-December in January. There are companies with significant float changes from end-September and/or end-December.
  • The changes in free float could be reflected in domestic and global indices over the next few weeks and months resulting in action from passive trackers.
  • There are 15 stocks that could have passive inflows from global trackers while 9 could see passive outflows in February.

Concord Biotech’s US$650m Lock-Up Expiry – Some Could Be Tempted to Book Multi-Bagger Gains

By Clarence Chu

  • Concord Biotech Ltd (658823Z IN) listed in India on 18th Aug 23 after raising US$188m. The IPO had been a 100% secondary selldown with Helix Investment selling its entire stake.
  • Concord Biotech (Concord) is an India-based biopharma firm, which develops and manufactures fermentation-based active pharmaceutical ingredients (APIs).
  • Coming up for six-month lockup expiry on 7th Feb 24 are the firm’s pre-IPO shareholders, along with a portion of its promoters’ stake.

Apeejay Surrendra Park Hotels IPO – Has Bounced Back Strongly, at a Decent Discount

By Sumeet Singh

  • Apeejay Surrendra Park Hotel (PARK IN) (ASPH) plans to raise up to US$111m via selling a mix of primary and secondary shares in its India IPO.
  • ASPH ranks as the eighth largest in India in terms of chain affiliated hotel rooms inventory as of Sep 2023, as per Horwath HTL Report.
  • In this note, we talk about the past performance and our thoughts on valuations.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars